Okadaic acid disrupts Golgi structure and impairs enzyme synthesis and secretion in the rat pancreas.
Okadaic acid, a serine/threonine phosphatase inhibitor, has been shown to inhibit rat pancreatic enzyme secretion by interference with late processes in stimulus-secretion coupling. To further characterize its action, we studied the effect of okadaic acid on secretion of newly synthesized proteins, protein synthesis, and cellular ultrastructure in pancreatic lobules derived from rats stimulated in vivo by feeding the synthetic proteinase inhibitor FOY-305. Okadaic acid completely blocked protein secretion at concentrations that inhibit the Ca2+/calmodulin-dependent protein phosphatase 2b, calcineurin. Protein synthesis was abolished at 10(-6) mol/l and reduced by 60% at 5 x 10(-7) mol/l okadaic acid. Pancreatic lobules exposed to 5 x 10(-7) mol/l okadaic acid for 20 min fully restored their secretory capacity on removal of the drug; whereas, after a preincubation with okadaic acid for > 40 min, protein secretion remained impaired during the recovery period. Electron microscopic examination of pancreatic acinar cells treated with 5 x 10(-7) mol/l okadaic acid revealed a dilated Golgi complex after 15 and 30 min and a subsequent fragmentation of Golgi cisternae into clouds of small uniform vesicles after 60 min. Reassembly of Golgi stacks occurred after a 60-min recovery without okadaic acid. These data indicate that serine/threonine phosphatases play an important role not only in the regulation of pancreatic enzyme synthesis and exocytosis but also are crucial for the maintenance of normal Golgi architecture and function in the exocrine rat pancreas. These effects are probably not exclusively mediated via type 2b calcineurin-like protein phosphatases.
Waschulewski
I H
IH
I. Department of Medicine, Christian-Albrechts-University of Kiel, Germany.
Kruse
M L
ML
Agricola
B
B
Kern
H F
HF
Schmidt
W E
WE
D000818:Animals; D002766:Cholecystokinin / Q000502:physiology; D004798:Enzymes / Q000096:biosynthesis / Q000378:metabolism; D004952:Esters; D004988:Ethers, Cyclic / Q000494:pharmacology*; D016670:Gabexate / Q000031:analogs & derivatives*; D006056:Golgi Apparatus / Q000187:drug effects* / Q000648:ultrastructure*; D006146:Guanidines / Q000494:pharmacology; D008297:Male; D008854:Microscopy, Electron; D019319:Okadaic Acid; D010179:Pancreas / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology*; D011480:Protease Inhibitors / Q000494:pharmacology; D014176:Protein Biosynthesis; D051381:Rats; D017208:Rats, Wistar
D004798:Enzymes; D004952:Esters; D004988:Ethers, Cyclic; D006146:Guanidines; D011480:Protease Inhibitors; C034532:camostat; D019319:Okadaic Acid; D016670:Gabexate; D002766:Cholecystokinin